Ebola Virus Disease

Ebola, also known as Ebola hemorrhagic fever or Ebola viral disease, is a rare and deadly illness caused by one of the strains of Ebola virus. This viral agent is regarded as a prototype pathogen of viral hemorrhagic fever, with high fatality rates in humans and primates.

What is Ebola Virus Disease?

Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe infectious disease illness caused by the Zaire ebolavirus.

Ebola Virus History

Ebola Virus Epidemiology

What are the Symptoms of Ebola Virus?

Ebola Virus Disease Diagnosis and Treatment

Prevention of Ebola Virus

Ebola research: an interview with Professor Easton, University of Warwick

Ebola-Neutralizing Antibodies

Latest Ebola Virus Disease News and Research

Study reveals evidence of 22 viruses in human semen post-infection

This study uncovers the persistence of 22 viruses in human semen, emphasizing the need for updated public health strategies and insights into fertility impacts.

16 Dec 2024

New toolkit aims to help U.S. hospitals spot deadly viral hemorrhagic fevers faster and safer

Researchers develop a laboratory toolkit to assist frontline healthcare facilities or the care of patients with suspected viral hemorrhagic fevers.

30 Oct 2024

Diagnostic toolkit aims to improve response to Marburg virus cases

Viral hemorrhagic fevers (VHF) such as Marburg virus disease have been in the news recently, with more than 60 cases of Marburg confirmed in Rwanda.

26 Oct 2024

PulmoBioMed raises £1.4m for innovative lung test commercialization

PulmoBioMed - a Northumbria University spin-out which has developed a new lung test that could lead to earlier diagnosis of asthma and other conditions - has raised £1.4m to help commercialize its technology.

12 Feb 2024

Pediatric viral threats surge in the 21st century: A call for One Health approach

Scoping review in "Pediatric Research" examines the rise of pediatric viral diseases in the 21st century and underscores the importance of a One Health approach, integrating human, animal, and ecosystem health, to combat these emerging and re-emerging infectious threats effectively.

9 Nov 2023

CEPI and University of Oxford launch new project to initiate vaccine development against Junín virus

The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford today announced the launch of a new project to initiate early development of prototype vaccines against the Junín virus, selected as an exemplar of the Arenavirus family which is responsible for multiple deadly hemorrhagic fevers with epidemic and pandemic potential.

6 Nov 2023

CEPI and HMRI partner to accelerate development of pandemic vaccines

CEPI, the Coalition for Epidemic Preparedness Innovations, and the Houston Methodist Research Institute (HMRI), have today announced a partnership to combine cutting-edge artificial intelligence (AI) technology with established laboratory techniques to speed up development of future vaccines against novel viral threats (also known as Disease X).

18 Jul 2023

From COVID-19 to future threats: building a global genomic surveillance network

Researchers present a modular framework for global sustainable networks of viral genomic surveillance.

16 Jun 2023

University Hospital Centre for Emerging Viral Diseases named as a WHO collaborating center for epidemic and pandemic diseases

The World Health Organization (WHO), the University of Geneva (UNIGE) and Geneva University Hospitals (HUG), yesterday formalized the designation of the University Hospital Centre for Emerging Viral Diseases as a WHO collaborating center for epidemic and pandemic diseases.

8 Jun 2023

Global mapping of bushmeat activity to improve zoonotic spillover surveillance

Researchers use geospatial models based to predict the rural global areas of bushmeat activity.

28 Mar 2023

Experimental vaccine completely protects cynomolgus macaques against lethal Sudan virus

A National Institutes of Health research group with extensive experience studying ebolavirus countermeasures has successfully developed a vaccine against Sudan virus (SUDV) based on the licensed Ebola virus (EBOV) vaccine.

3 Feb 2023

Experimental vaccine against Marburg virus shows promise in first-in-human clinical trial

A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial.

30 Jan 2023

State-of-the-art Biocontainment Unit opened at MedStar Washington Hospital Center

MedStar Washington Hospital Center has opened a state-of-the-art Biocontainment Unit that will be used primarily for observation and flexed for respiratory isolation and further flexed to care for patients with highly infectious diseases.

19 Jan 2023

World Health Organization reports insufficient evidence to support syndromic screening for COVID-19

According to a scientific brief by the World Health Organization (WHO), there is insufficient information to implement syndromic COVID-19 testing for SARS-CoV-2 transmission prevention across land borders.

28 Dec 2022

Clinical trials demonstrate safety and efficacy of Ebola Zaire vaccines

Two vaccines against the Zaire strain of Ebola virus are immunogenic and safe in both adults and children, according to initial results from two phase II clinical trials published in the New England Journal of Medicine.

21 Dec 2022

Trial of three vaccines for Zaire Ebola virus disease

Researchers perform two randomized controlled trials to determine immunogenicity and safety of three Ebola vaccines.

20 Dec 2022

Trial results confirm the safety of three different Ebola vaccine regimens

Ebola epidemics occur periodically in various sub-Saharan African countries. While vaccines exist and have already received WHO Prequalification against the Zaire ebolavirus species, it is essential to pursue and intensify efforts to supplement the available data to develop a safe and effective Ebola vaccine strategies in adults and children alike.

16 Dec 2022

Randomized trials demonstrate the safety of Ebola vaccine regimens in adults and children

Two randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens were safe in both age groups, according to results published today in the New England Journal of Medicine.

15 Dec 2022

Best practices and challenges in One Health approach to fight zoonotic diseases

Announcing a new article publication for Zoonoses journal. Zoonoses are infectious diseases that can be transmitted from animals to humans and/or from humans to animals.

1 Dec 2022

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC).

12 Oct 2022

Ebola Virus Disease

Overview

Ebola Virus History

Ebola Virus Epidemiology

What are the Symptoms of Ebola Virus?

Feature Articles

Ebola Virus Disease Diagnosis and Treatment

Prevention of Ebola Virus

Ebola research: an interview with Professor Easton, University of Warwick

Ebola-Neutralizing Antibodies

Latest Ebola Virus Disease News and Research

Study reveals evidence of 22 viruses in human semen post-infection

New toolkit aims to help U.S. hospitals spot deadly viral hemorrhagic fevers faster and safer

Diagnostic toolkit aims to improve response to Marburg virus cases

PulmoBioMed raises £1.4m for innovative lung test commercialization

Pediatric viral threats surge in the 21st century: A call for One Health approach

CEPI and University of Oxford launch new project to initiate vaccine development against Junín virus

CEPI and HMRI partner to accelerate development of pandemic vaccines

From COVID-19 to future threats: building a global genomic surveillance network

University Hospital Centre for Emerging Viral Diseases named as a WHO collaborating center for epidemic and pandemic diseases

Global mapping of bushmeat activity to improve zoonotic spillover surveillance

Experimental vaccine completely protects cynomolgus macaques against lethal Sudan virus

Experimental vaccine against Marburg virus shows promise in first-in-human clinical trial

State-of-the-art Biocontainment Unit opened at MedStar Washington Hospital Center

World Health Organization reports insufficient evidence to support syndromic screening for COVID-19

Clinical trials demonstrate safety and efficacy of Ebola Zaire vaccines

Trial of three vaccines for Zaire Ebola virus disease

Trial results confirm the safety of three different Ebola vaccine regimens

Randomized trials demonstrate the safety of Ebola vaccine regimens in adults and children

Best practices and challenges in One Health approach to fight zoonotic diseases

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Ebola Virus Disease

Overview

Feature Articles

Ebola Virus Disease Diagnosis and Treatment

Prevention of Ebola Virus

Ebola research: an interview with Professor Easton, University of Warwick

Ebola-Neutralizing Antibodies

Latest Ebola Virus Disease News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in